Ian Stines, MD
Vascular Surgery · Bowling Green, KYNPI 1952711665
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $7,450 and has fallen 88.1% since, to $888 in 2025.
Across 99 payments — averaging $175.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- W. L. Gore & Associates, Inc.$2K
- Penumbra, Inc.$1K
- Boston Scientific$508
- Cook Medical LLC$466
- Endologix LLC$351
- plus $669 from 10 others
What the payments were for
- Grants$10,00057%
- Travel & lodging$7845%
- Food & beverage$6,19736%
- Education$4363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 29 | $12,150 |
| W. L. Gore & Associates, Inc. | 23 | $2,077 |
| Penumbra, Inc. | 6 | $1,196 |
| Boston Scientific | 17 | $508 |
| Cook Medical LLC | 7 | $466 |
| Endologix LLC | 4 | $351 |
| Silk Road Medical, Inc. | 2 | $156 |
| TELA Bio, Inc. | 2 | $132 |
| Viz.ai, Inc. | 1 | $102 |
| Bolton Medical Inc | 1 | $83 |
| Lemaitre Vascular, Inc. | 1 | $68 |
| Integra Lifesciences Corporation | 2 | $40 |
| Johnson & Johnson | 1 | $26 |
| Terumo Medical Corporation | 1 | $24 |
| Abiomed | 1 | $22 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$5,340
- ENDURANT IIS$5,116
- Indigo System$795
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$542
- Heli-FX EndoAnchor System$484
- GORE TAG Thoracic Branch Endoprosthesis$326
- GORE VIABAHN Endoprosthesis with Heparin$197
- HawkOne$160
- Penumbra System$146
- ENROUTE Transcarotid Neuroprotection System$143
- ENROUTE Transcarotid Stent$143
- PERFORMER$139
- Valiant Captivia$133
- Alto Abdominal Stent Graft System$130
- Vascular Graft$125
- Zenith$105
- Viz.AI LVO$102
- EXCLUDER AAA Endoprosthesis$102
How this compares
$17,417 in reported general payments places this provider in the 70th percentile of 72 vascular surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $9,314 |
| XareltoRivaroxaban | 11 | $5,978 |
| Cilostazol | 33 | $685 |
| ClopidogrelClopidogrel Bisulfate | 63 | $412 |
| Oxycodone Hcl | 23 | $147 |
| Pentoxifylline | 16 | $144 |
| Atorvastatin Calcium | 37 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $26 | $5,97811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 72 vascular surgery providers in Kentucky.
Other vascular surgery in Bowling Green
- Brian GrantBowling Green$27K
- Shane OkeeffeBowling Green$6K
- Chen RubinsteinBowling Green$3K
- Amit DwivediLouisville$406K
- Igor VoskresenskyLexington$99K
- Nick AbediLexington$95K
- Abindra SigdelLouisville$84K
- Samuel TyagiLexington$70K
- Ferenc NagyLouisville$47K
- Gregory SchmiederLouisville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.